News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
The 3rd Annual Burrill Digital Health Meeting
February 07, 2012 - February 08, 2012
In the not too distant future, nearly all of healthcare will be digitized. Technology is being developed that will connect patients and physicians in real-time. In turn, doctors will be able to practice medicine from virtually anywhere at anytime, with instant access to the information and systems they need. The 3rd Annual Burrill Digital Health Meeting will showcase the underlying issues, emerging business opportunities, and cutting-edge innovations.
The 3rd Annual Burrill Pan-Asia Life Sciences Meeting
June 17, 2012
The Burrill Pan-Asia Life Sciences Meeting brings together government and industry leaders from China, India, South Korea, Malaysia, Singapore, Taiwan, Australia, and New Zealand to discuss the attractive government incentives that are in place designed to attract global life sciences companies to these countries. In addition CEOs will also provide a ground-level view and give their own experiences about doing business in Pan-Asian countries.
Life Science Innovation Northwest
July 11, 2012 - July 12, 2012
The Pacific Northwest is home not only to many of the life sciences’ superstars but also to many of the industry’s most promising startups. Increasingly, companies in this enterprising region are developing technology for use beyond just human healthcare, embracing fields such as wellness, agriculture, biomaterials, and biofuels. This meeting focuses on the state of the biotech industry in the Pacific Northwest and worldwide.
The Burrill Personalized Medicine Meeting
September 13, 2012 - September 14, 2012
The 8th Annual Burrill Personalized Medicine Meeting is a two-day event, which encompasses detailed discussions on the whole spectrum of personalized medicine – from personalized medicine prediction to prevention to personalized care – provides attendees with a detailed “window” into the personalized medicine world and the 2012 challenges and opportunities this paradigm presents.
Burrill & Company 12th Annual Reception
January 10, 2012
Burrill & Company is pleased to host an annual reception during the JP Morgan Annual Healthcare Conference. This will be our 12th year—bringing together the biggest names in the biotech, pharmaceutical and healthcare industries in a lively setting with exceptional wines, hors d’oeuvres and live entertainment.
› See all 2013 2012 2011 2010 2009 2008
